当前位置: 首页 >> 检索结果
601. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
作者: Paula Lozano.;Nora B Henrikson.;Caitlin C Morrison.;John Dunn.;Matt Nguyen.;Paula R Blasi.;Evelyn P Whitlock.
来源: JAMA. 2016年316卷6期634-44页
Multifactorial dyslipidemia, characterized by elevated total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C), is associated with dyslipidemia and markers of atherosclerosis in young adulthood. Screening for dyslipidemia in childhood could delay or reduce cardiovascular events in adulthood.
602. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
作者: .;Kirsten Bibbins-Domingo.;David C Grossman.;Susan J Curry.;Karina W Davidson.;John W Epling.;Francisco A R García.;Matthew W Gillman.;Alex R Kemper.;Alex H Krist.;Ann E Kurth.;C Seth Landefeld.;Michael LeFevre.;Carol M Mangione.;Douglas K Owens.;William R Phillips.;Maureen G Phipps.;Michael P Pignone.;Albert L Siu.
来源: JAMA. 2016年316卷6期625-33页
Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovascular disease in adults.
603. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
Various noninvasive ventilation strategies are used to prevent bronchopulmonary dysplasia (BPD) of preterm infants; however, the best mode is uncertain.
604. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.
作者: Maryam Afkarian.;Leila R Zelnick.;Yoshio N Hall.;Patrick J Heagerty.;Katherine Tuttle.;Noel S Weiss.;Ian H de Boer.
来源: JAMA. 2016年316卷6期602-10页
Diabetic kidney disease is the leading cause of chronic and end-stage kidney disease in the United States and worldwide. Changes in demographics and treatments may affect the prevalence and clinical manifestations of diabetic kidney disease.
605. Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.
作者: Stephan Haussig.;Norman Mangner.;Michael G Dwyer.;Lukas Lehmkuhl.;Christian Lücke.;Felix Woitek.;David M Holzhey.;Friedrich W Mohr.;Matthias Gutberlet.;Robert Zivadinov.;Gerhard Schuler.;Axel Linke.
来源: JAMA. 2016年316卷6期592-601页
Stroke remains a major predictor of mortality after transcatheter aortic valve implantation (TAVI). Cerebral protection devices might reduce brain injury as determined by diffusion-weighted magnetic resonance imaging (DWMRI).
|